Beyond Neuroinflammation: Targeting the Microbe–Barrier–Brain Axis Through Precision Nutrition in Neurological Long COVID (Neuro-PASC)
Nutrients · 2026
DOI: 10.3390/nu18203420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Amador Velázquez De Castro-Bono und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Central de La Defensa "Gómez Ulla", 28047 Madrid, Spain. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome, Neuroinflammatory Diseases, Precision Medicine. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post-acute Neurological Sequelae of SARS-CoV-2 infection (Neuro-PASC) contribute substantially to Long COVID-related disability, with cognitive impairment, chronic fatigue, dysautonomia, and neuropsychiatric symptoms among its most debilitating manifestations. Although its pathogenesis remains incompletely understood, evidence implicates persistent immune activation, intestinal barrier dysfunction, microbiota dysbiosis, microbiome-derived metabolic alterations, mitochondrial dysfunction, and neuroimmune interactions in sustaining neuroinflammation and neurological impairment. This narrative review examines precision nutrition as a potential pathway-oriented strategy for Neuro-PASC. We synthesise evidence linking the gut microbiota, intestinal permeability, immunometabolic pathways, mitochondrial function, and neurological outcomes, while evaluating nutritional interventions targeting these mechanisms. We focus on candidate biomarkers, including serum zonulin, fatty acid-binding protein 2 (FABP2), faecal short-chain fatty acids (SCFAs), and the kynurenine-to-tryptophan ratio, which may support patient stratification and personalised nutritional strategies. We also propose a stepwise framework involving dietary stabilisation, functional foods, targeted supplementation, and microbiome-based interventions, alongside practical considerations for post-exertional symptom exacerbation, dysautonomia, and mast cell-related symptoms. Finally, we identify priorities for future research, including multi-omics integration, artificial intelligence, digital health, and biomarker-stratified randomised controlled trials. Because current evidence remains predominantly observational and mechanistic, precision nutrition should be considered a complementary strategy requiring rigorous clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Central de La Defensa "Gómez Ulla", 28047 Madrid, Spain.
- Department of Nursing, Physiotherapy and Medicine, University of Almería, 04120 Almería, Spain.
- Food Technology Division, University of Almería, 04120 Almería, Spain.
ORCID-Profile: Gracia Castro-Luna, José Luis Guil-Guerrero
Zitieren
APA
Velázquez De Castro-Bono, A., Castro-Luna, G., & Guil-Guerrero, J. L. (2026). Beyond Neuroinflammation: Targeting the Microbe–Barrier–Brain Axis Through Precision Nutrition in Neurological Long COVID (Neuro-PASC). Nutrients. https://doi.org/10.3390/nu18203420
Vancouver
Velázquez De Castro-Bono A, Castro-Luna G, Guil-Guerrero JL. Beyond Neuroinflammation: Targeting the Microbe–Barrier–Brain Axis Through Precision Nutrition in Neurological Long COVID (Neuro-PASC). Nutrients. 2026. doi:10.3390/nu18203420
BibTeX
@article{VelzquezDeCastroBono2026,
author = {Velázquez De Castro-Bono, Amador and Castro-Luna, Gracia and Guil-Guerrero, José Luis},
title = {Beyond Neuroinflammation: Targeting the Microbe–Barrier–Brain Axis Through Precision Nutrition in Neurological Long COVID (Neuro-PASC)},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18203420}
}
EUVIMED